3[2]Desloge RB ,Finstad CL, Sassoon J, et al. Altered regulation of cell surface peptidases in human cholesteatoma. Otolaryngology Head and Neck Surgery .1997, 116: 58-63.
4[3]Sudhoff H, Bujia J, Fisseler-Eekhoff A, et al. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope. 1995,105: 1227-1231.
5[4]Tanaka Y, Shiwa M, Kojima H, et al. A study on epidermal prolifilation ability in cholesteatomas. Laryngoscope,1998,108: 537-542.
6[6]Tanaka Y, Kojima H, Miyazaki H, et al. Roles of cytokines and cell cycle regulating substances in prolifiration of cholesteatoma epithelium. Laryngoscope. 1999,109:1102-1107.
7[7]Gerdes J, Schwab U, Lemke H, Stein H. Production of mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983, 31: 13-20.
8[8]Mayot D, Bene MC, Perrin C, et al. Restricted expression of Ki-67 in cholesteatoma epithelium. Arch Otolaryngol Head Neck Surg.1993,119:656-658.
9[9]Ergun S, Zheng X, Carlsoo B. Antigen expression of epithelial markers, collagen Ⅳ and Ki67 in middle ear cholesteatoma. An immunohistochemical Study. Acta Otolaryngol. 1994,114:295-302.
10[10]Bujia J, Holly A, Antoli-Candela F, et al. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1. Laryngoscope. 1996,106:865-868.
